Tomoyuki Kurashige

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients

S. Okada, M. Kohjima, Y. Ogawa, 2019, Canadian journal of gastroenterology & hepatology.

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study

M. Nakamuta, M. Kohjima, Tsuyoshi Yoshimoto, 2022, Medicine.

The Combination of Nucleotide Analog Therapy and Steroid Pulse Therapy for Acute HBV Infection Effectively Promotes HBV Clearance

M. Kohjima, Y. Ogawa, Masaki Kato, 2021, Gastroenterology Insights.